About the bill
- Full Title
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 2019.
7 cosponsors (5D, 1I, 1R) (show)(joined Feb 4, 2013)(joined Feb 4, 2013)(joined Feb 4, 2013)(joined Feb 4, 2013)(joined Mar 14, 2013)(joined May 14, 2013)(joined Jan 16, 2014)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 214 — 113th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/113/s214
“S. 214 — 113th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2013. July 25, 2016 <https://www.govtrack.us/congress/bills/113/s214>
|title=S. 214 (113th)
|accessdate=July 25, 2016
|author=113th Congress (2013)
|date=February 4, 2013
|quote=Preserve Access to Affordable Generics Act